Results 201 to 210 of about 82,620 (274)

Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia [PDF]

, 1985
F Caligaris-Cappio, G Pizzolo, M Chilosi, L Bergui, Gianpietro Semenzato, L Tesio, L Morittu, F Malavasi, M Gobbi, R Schwarting   +9 more
openalex   +1 more source

Illuminating Immunity: A Systematic Review of Immune Cell Autofluorescence

Journal of Biophotonics, EarlyView.
ABSTRACT Immunophenotyping provides valuable prognostic and diagnostic information, but is technically complex and expensive. The assessment of autofluorescence is label‐free and provides complex information on cell identity. However, research on its application to immunophenotyping has been heterogenous.
Aline Knab, Caroline Giardina, Shane T. Grey, Ewa M. Goldys, Jared M. Campbell   +4 more
wiley   +1 more source

Commentary on "real world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: a meta-analysis of clinical studies". [PDF]

BMC Pharmacol Toxicol
Namdar AB, Keikha M.
europepmc   +1 more source

Cytoskeleton organization is aberrantly rearranged in the cells of B chronic lymphocytic leukemia and hairy cell leukemia [PDF]

, 1986
F Caligaris-Cappio, L Bergui, L Tesio, G Corbascio, F Tousco, PC Marchisio   +5 more
openalex   +1 more source

Chronic lymphocytic leukemia progenitor cells carry the antigens T65, BA-1, and Ia [PDF]

, 1983
RT Perri, I Royston, Tucker W. LeBien, NE Kay   +3 more
openalex   +1 more source

The Impact of Survival Benefit and Study Design on FDA Approval for Anticancer Drugs Over the Past Decades

The Journal of Clinical Pharmacology, EarlyView.
Abstract Despite the tremendous effort in the oncology community, the success rate of anticancer development remained low at 30% to 40% from the Phase 3 study to the regulatory approval. The factors associated with the regulatory approval for market authorization have gained interest in the community to improve the success rate of drug development ...
Koji Ishizuka, Shunsuke Ono
wiley   +1 more source

Editorial: Reviews in hematologic malignancies: 2023

Frontiers in Oncology
Billy Michael Chelliah Jebaraj, Michael Liew, Felix Seyfried   +2 more
doaj   +1 more source

Dysregulated MicroRNAs in Chronic Lymphocytic Leukemia. [PDF]

Cureus
Mesaros O, Veres S, Onciul M, Matei E, Jimbu L, Neaga A, Zdrenghea M.   +6 more
europepmc   +1 more source

Interleukin 2 production in B cell chronic lymphocytic leukemia [PDF]

, 1985
JF Rossi, B Klein, T Commes, Michel Jourdan   +3 more
openalex   +1 more source

Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic Lymphocytic Leukemia. [PDF]

Eur J Haematol
Puckrin R, Owen C, Peters A.
europepmc   +1 more source